Key Highlights
- Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19% on October 15, with a market value of USD 1.6 billion, with a market value of USD 1.6 billion, with a market value of USD 1.6 billion.
- Cronos Group (NASDAQ:CRON) rose 1.74% on October 15, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion.
- Taboola.com (NASDAQ:TBLA) rose 2.05% on October 15, with a market value of USD 942.84 million, with a market value of USD 942.84 million, with a market value of USD 942.84 million, with a market value of USD 942.84 million.
- Ardelyx (NASDAQ:ARDX) rose 3.76% on October 15, with a market value of USD 824.81 million, with a market value of USD 824.81 million, with a market value of USD 824.81 million, with a market value of USD 824.81 million.
Melco Resorts and Entertainment (NASDAQ:MLCO): Valuation in Focus
Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19% to a listed USD 4.25 on 769,200 shares, with a market capitalization of USD 1.6 billion, a P/E of 7.11. Melco Resorts and Entertainment, classified in consumer services, rose 1.19% to USD 4.25 on October 15 on 769,200 shares, with a market value of USD 1.6 billion. Melco Resorts reported second-quarter net income of USD 22.7 million, or USD 0.06 per ADS, and operating income of USD 127.8 million, while adjusted property EBITDA fell to USD 303.8 million from USD 377.7 million a year earlier. At USD 4.25 the ADS trade at 7.11 times trailing earnings, with trailing EPS growth of 336%, on a market value of USD 1.6 billion. The decline in property EBITDA, about 20%, shows that trailing earnings overstate current run-rate profitability, so the low multiple reflects the Macau and Cyprus operating outlook. Trailing diluted EPS is USD 0.60, a P/E of 7.11, with EPS growth of 336.11% year on year. Small-cap equities with limited liquidity can move sharply on financing, guidance and macro headlines, and trailing earnings can overstate or understate current profitability. By market value it ranks 1 of 5 in this group. What to watch next: Macau gross gaming revenue, margins and debt reduction.
Cronos Group (NASDAQ:CRON): Valuation in Focus
Cronos Group (NASDAQ:CRON) rose 1.74% to a listed USD 3.22 on 323,080 shares, with a market capitalization of USD 1.18 billion, a P/E of 17.97. Cronos Group, classified in health technology, rose 1.74% to USD 3.22 on October 15 on 323,080 shares, with a market value of USD 1.18 billion. Cronos Group rose 1.74% to USD 3.22, with trailing EPS of USD 0.18, growth of 259.75% and a market value of USD 1.18 billion. The trailing earnings include non-operating items, so the 17.97 multiple should be cross-checked against operating results. Company-specific second-quarter results were not verified in this review, so the valuation case rests on the earnings trend and balance sheet. Trailing diluted EPS is USD 0.18, a P/E of 17.97, with EPS growth of 259.75% year on year. By market value it ranks 2 of 5 in this group. What to watch next: operating profitability, cash balance and regulatory developments.
Taboola.com (NASDAQ:TBLA): Valuation in Focus
Taboola.com (NASDAQ:TBLA) rose 2.05% to a listed USD 3.49 on 497,320 shares, with a market capitalization of USD 942.84 million, a P/E of 8.62. Taboola.com, classified in technology services, rose 2.05% to USD 3.49 on October 15 on 497,320 shares, with a market value of USD 942.84 million. Taboola reported second-quarter revenue of USD 476.8 million, up 2.4%, ex-TAC gross profit of USD 192.4 million, up 11.8%, adjusted EBITDA of USD 55.5 million, up 22.8% with a 28.8% margin, and net income of USD 4.3 million against a loss a year earlier. The shares fell about 30% to USD 3.71 on the August 5 report despite the raise, as revenue and gross profit missed guidance and Google policy changes and a publisher network cleanup weighed on growth. At USD 3.49 the stock trades at 8.62 times trailing earnings and its USD 942.8 million market value is about 4 times the midpoint of adjusted EBITDA guidance, before net debt, with USD 133.1 million of cash at quarter-end. Trailing diluted EPS is USD 0.40, a P/E of 8.62, with EPS growth of 1,003.00% year on year. By market value it ranks 3 of 5 in this group. What to watch next: ex-TAC gross profit growth, free cash flow conversion and Google policy effects.
Ardelyx (NASDAQ:ARDX): Valuation in Focus
Ardelyx (NASDAQ:ARDX) rose 3.76% to a listed USD 3.31 on 2,350,000 shares, with a market capitalization of USD 824.81 million. Ardelyx, classified in health technology, rose 3.76% to USD 3.31 on October 15 on 2,350,000 shares, with a market value of USD 824.81 million. Ardelyx reported second-quarter product revenue of USD 118.1 million, up 31%, led by IBSRELA at USD 86.2 million, up 33%, and XPHOZAH at USD 31.9 million, up 27%, its largest quarterly revenue. Cash and investments were USD 281.8 million at June 30, and the loss per share of USD 0.23 narrowed only 4.32%, so profitability remains the central valuation question. At USD 3.31 the shares trade at about 1.7 times the midpoint of combined 2026 product guidance on a market value of USD 824.8 million. Trailing diluted EPS is negative USD 0.23, with EPS growth of 4.32% year on year. By market value it ranks 4 of 5 in this group. What to watch next: IBSRELA growth, XPHOZAH market dynamics and the path to profitability.
Geron (NASDAQ:GERN): Valuation in Focus
Geron (NASDAQ:GERN) rose 2.94% to a listed USD 1.23 on 2,250,000 shares, with a market capitalization of USD 787.03 million. Geron, classified in health technology, rose 2.94% to USD 1.23 on October 15 on 2,250,000 shares, with a market value of USD 787.03 million. Geron reported second-quarter RYTELO net product revenue of USD 57.5 million, up 17% year on year and 11% from the first quarter, with first-half revenue of USD 109.2 million, up 24%. Cash and marketable securities were USD 326.9 million at June 30, and the second-quarter net loss was USD 16.7 million, or USD 0.02 a share. At USD 1.23 the shares trade at about 3.4 times the midpoint of 2026 revenue guidance on a market value of USD 787.0 million, while gross-to-net deductions of about 20.7% and a pending securities class action are risks. Trailing diluted EPS is negative USD 0.10, with EPS growth of 21.06% year on year. By market value it ranks 5 of 5 in this group. What to watch next: RYTELO demand growth, gross-to-net trends and the second-indication readout.
Where Things Stand
The largest names in the group have market values from USD 787 million to USD 1.6 billion, near the top of the small-cap range. Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19%. Cronos Group (NASDAQ:CRON) rose 1.74%. Taboola.com (NASDAQ:TBLA) rose 2.05%. Ardelyx (NASDAQ:ARDX) rose 3.76%. Geron (NASDAQ:GERN) rose 2.94%. Moves on stocks this small often reverse, so the balance of evidence favors waiting for filings and the next session. Direction remains unknown, and each name carries its own risks. Check each company's filings for the drivers behind the move, verify the latest filings before acting, and treat the figures as a snapshot.






Please wait processing your request...